Mixed signal: momentum 55/100, trend 68/100.
Prediction result · Ensemble engineUpdated 6:16 AM
ELVElevance Health, Inc. stock price outlook
Elevance Health, Inc. (ELV) is trading at $420.07, down 0.46% since the previous close and -4.52% over the past week. Price sits above its 50-day average by 2.32%, with price momentum at 55/100 and trend velocity at 68/100. Sentiment across 0 recent headlines reads mixed at 50/100. Volatility risk is contained (34/100) and the stock is 83% of the way up its 52-week range. The weighted factor score lands at 58/100 — a neutral signal. Research only, not investment advice.
Elevance Health, Inc.
- Elevance Health, Inc. (ELV) is trading at $420.07, down 0.46% since the previous close and -4.52% over the past week. Price sits above its 50-day average by 2.32%, with price momentum at 55/100 and trend velocity at 68/100. Sentiment across 0 recent headlines reads mixed at 50/100. Volatility risk is contained (34/100) and the stock is 83% of the way up its 52-week range. The weighted factor score lands at 58/100 — a neutral signal. Research only, not investment advice.
- Bull input: Oscillator at 62 — healthy uptrend region.
- Bear input: No bearish case in the sources.
Signals are model output from public data, not personalized investment advice.
Invalidate when a clear catalyst or directional print replaces the mixed tape.
AI Signal
Neutral · Playable
Full public-market mode: chart history, quote, and news inputs were available.
Chart feed
Cron market chart feed
Quote/history
Six-month public chart history loaded.
News feed
No relevant current headlines found.
Signal inputs
Technical factors and news sentiment evaluated across multiple signal inputs.
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Why It Matters
Signal Explanation
Elevance Health, Inc. (ELV) is trading at $420.07, down 0.46% since the previous close and -4.52% over the past week. Price sits above its 50-day average by 2.32%, with price momentum at 55/100 and trend velocity at 68/100. Sentiment across 0 recent headlines reads mixed at 50/100. Volatility risk is contained (34/100) and the stock is 83% of the way up its 52-week range. The weighted factor score lands at 58/100 — a neutral signal. Research only, not investment advice.
Analyst Engine · Specialist model ensemble
Trees disagree — no clear lean on ELV
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Sentiment 50/100 + price -0.5% are both mid-range.
Volume read 32/100 with price drift -0.5% — no clear footprint.
Vol regime 34/100 is mid-range — no edge.
Near range top — needs fresh catalyst to break out.
Sentiment 50/100 vs week change -4.5% are in agreement — no divergence edge.
Price within 2.3% of the 50d SMA — no clear structural read.
Oscillator at 62 — healthy uptrend region.
Momentum 55/100 is not strong enough to confirm a breakout.
News 50/100 and weekly change -4.5% do not create a clean follow-through read.
Volume 32/100 is quiet while trend velocity stays firm — supply looks thin.
Volatility 34/100 does not give a clean compression read.
Range position 83% is too middle-of-the-road to matter.
Sentiment 50/100 and momentum 55/100 are not aligned enough for a clean read.
50d SMA distance 2.3% is not decisive.
Oscillator at 62 does not show a rebound edge.
Why the ensemble agrees
- Mixed signal: momentum 55/100, trend 68/100.
- Near range top — needs fresh catalyst to break out.
- Sentiment 50/100 + price -0.5% are both mid-range.
Counter-trees
- Volume 32/100 is quiet while trend velocity stays firm — supply looks thin.
- Oscillator at 62 — healthy uptrend region.
Bull Case
- Oscillator at 62 — healthy uptrend region.
- Volume 32/100 is quiet while trend velocity stays firm — supply looks thin.
Bear Case
- No bearish case in the sources.
Latest Market Headlines
Headline titles only, from the publisher named on each card. Each links to the original story.
Key stats
- Sector
- Health Care
- Industry
- Medical Specialities
- Market cap
- $90.76B
- 52-week range
- $450.69/$274.84
- Volume
- 1,286,917
- Analyst 1-yr target
- $490.00
- Exchange
- NYSE
Source: Nasdaq public quote data. Research only.
Insider trades
0 buys · 13 sells by ELV insiders (SEC Form 4 filings)
- SELL Kaye Mark EVP & CFO · 2026-10-23$1.03M
- SELL Kaye Mark EVP & CFO · 2026-10-23$758K
- SELL Kaye Mark EVP & CFO · 2026-10-23$724K
- SELL Kaye Mark EVP & CFO · 2026-10-23$510K
- SELL Kaye Mark EVP & CFO · 2026-10-23$369K
- SELL Kaye Mark EVP & CFO · 2026-10-23$245K
Earnings Intelligence
Next
Not yet scheduled
Estimate
N/A
Actual
$6.99
- • Last report Oct 21, 2026 (Sep 2026): EPS $6.99 vs $4.66 expected, +50% surprise.
- • Beat estimates in 4 of the last 4 quarters.
Risk Warnings
- • Signals are model output from public data, not personalized investment advice.
- • Markets can move against any signal regardless of the score.
- • Confirm liquidity, spreads, and your own thesis before acting.
ELV questions
What is the MarketPicks AI signal for Elevance Health, Inc. stock (ELV)?
As of Nov 2, 1:16 AM ET, the ensemble reads neutral on ELV — no consensus — 14 of 16 bots holding, with 2 bull, 0 bear and 14 hold votes from 16 specialist bots. Research only, not investment advice.
What is the latest ELV price on MarketPicks?
ELV was $420.07 on the latest quote (Nov 2, 1:16 AM ET), -0.46% since the previous close. Quotes can be delayed.
What do the momentum and trend scores for ELV mean?
Scores run from 0 to 100, with 50 neutral. ELV shows momentum 55/100, trend velocity 68/100 and volatility risk 34/100, with news sentiment at 50/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.